Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study

Journal of Bone and Mineral Research

Volumn 16, Issue 10, 2001, Pages 1846-1853

  Dempster, D W ^a   Cosman, F ^a   Kurland, E S ^a   Zhou, H ^a   Nieves, J ^a   Woelfert, L ^a   Shane, E ^a   Plavetic K ^a   Muller R ^a   Bilezikian, J ^a   Lindsay, R ^a  

^a HELEN HAYES HOSPITAL   (United States)

Author keywords

Bone microarchitecture; Human; Osteoporosis; Parathyroid hormone

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MINERAL; CANCELLOUS BONE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; ILIAC CREST; MALE; MORPHOMETRICS; OSTEOPOROSIS; PERIMETER; POROSITY; POSTMENOPAUSE; THREE DIMENSIONAL IMAGING; UNITED STATES;

BONE AND BONES; BONE DENSITY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ILIUM; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034812187     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.10.1846     Document Type: Article

References (55)

1. Studies of calcium phosphorus metabolism. V. A study of the bone trabeculae as a readily available reserve supply of calcium
2. On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol
3. Preliminary trial of low doses of human parathyroid 1-34 peptide in treatment of osteoporosis
4. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial
5. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-84) and 1, 25 dihydroxy vitamin D
6. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency
7. Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
8. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in post-menopausal women with osteoporosis
9. Parathyroid hormone 1-34 (hPTH 1-34) and estrogen produce dramatic bone density increases in post-menopausal osteoporosis - Results from a placebo-controlled randomized trial
10. Parathyroid hormone can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial
11. Parathyroid hormone in combination with estrogen dramatically reduces vertebral fracture risk
12. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
13. Treatment of osteoporosis with parathyroid peptide (h-PTH 1-34) and oestrogen: Increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone
14. Histomorphometric evidence of increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis
15. Insulin-like growth factor-I in men with idiopathic osteoporosis
16. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers
17. Bone quantification and dynamics of bone turnover by histomorphometric analysis
18. The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure
19. Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women
20. Histomorphometric assessment of bone mass, structure, and remodeling: A comparison between healthy black and white premenopausal women
21. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism
22. Bone histomorphometry: Standardization of nomenclature, symbols, and units
23. Amount of bone in iliac crest biopsy: Significance of the trabecular bone volume. Its values in normal and in pathological conditions
24. Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest and calcaneous
25. Marching cubes: A high resolution 3D surface construction algorithm
26. Volume and surface area of viable chondrocytes in situ using geometric modelling of serial confocal sections
27. A new method for the model independent assessment of thickness in three-dimensional images
28. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions
29. Three dimensional methods for quantification of cancellous bone architecture
30. Editorial: Sequential parathyroid hormone/alendronate therapy for osteoporosis - Robbing Peter to pay Paul?
31. Biologically meaningful determinants of the in vitro strength of lumbar vertebrae
32. The thickness of human vertebral cortical bone and its changes in aging and osteoporosis: A histomorphometric analysis of the complete spinal column from thirty-seven autopsy specimens
33. Bone structure in patients with low bone mineral density with or without vertebral fractures
34. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum
35. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats
36. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats
37. Anabolic effects of human biosynthetic parathyroid fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits
38. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone
39. PTH augments similar cortical bone in rats regardless of ovarian status - A histomorphometric analysis
40. Comparison of bone formation responses to parathyroid hormone (1-34), (1-31), and (2-34) in mice
41. PTH effects in the femur: Envelope-specific responses by 3D-QCT in post-menopausal women
42. Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles
43. Parathyroid hormone (PTH 1-34) as a treatment for idiopathic osteoporosis in men: Changes in bone mineral density, bone markers, and optimal duration of therapy
44. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence
45. Connectivity and the elastic properties of cancellous bone
46. Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling
47. The relationship between three-dimensional connectivity and the elastic properties of trabecular bone
48. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol
49. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats
50. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis
51. Trabecular structure in patients with primary hyperparathyroidism
52. Direct stereological estimation of three-dimensional connectivity in rat vertebrae: Effects of estrogen, etidronate and risedronate following ovariectomy
53. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)
54. Trabecular architecture in iliac crest bone biopsies: Intraindividual variability in structural parameters and changes with age
55. Relationships between quantitative histological measurements and non-invasive assessments of bone mass